Showing 1021-1030 of 10620 results for "".
Improving Mastectomy Scars with the Vbeam Prima
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-mastectomy-scars-with-the-vbeam-prima/19692/Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these women get the treatment they deserve post-surgery and uses the Vbeam Prima, a pulsed dye laser device, to help improve the appearance of the scars. WUpdates from Principia, Sebacia, and Candela
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranAntibiotics and the Mutant Selection Window
https://practicaldermatology.com/topics/atopic-dermatitis/antibiotics-and-the-mutant-protection-window/19537/When considering antibiotics for treating acne, Hilary Baldwin, MD says there's a new concept dermatologists should consider in preventing antibiotic resistance. She describes the mutant selection window and why a higher dose antibiotic may actually be safer and more effective.Guidelines for PsO, SRT; Promising Data from Sienna
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-guidelines-for-pso-srt-promising-data-from-sienna/19551/Two new guidelines from the American Academy of Dermatology and the National Psoriasis Foundation outline best practices for treating psoriasis, with a focus on comorbidities and biologic treatment. A new retrospective study shows a cure rate above 97 percent among older patients treated with superfHow to Plan a Dermatology Online Marketing Campaign that Works
https://practicaldermatology.com/topics/practice-management/marketingcampaign/18293/This Ekwa Marketing video outlines the method of coming up with an effective dermatology content marketing campaign. It also discusses the various tools that can help in this.NPF Services, Eskata Update, AAD Meeting Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-npf-services-eskata-update-aad-meeting-data/18326/The National Psoriasis Foundation is expanding its services to patients, with a special focus on teens affected by the Skin Disease. Widely anticipated by both physicians and patients, Eskata will be available for in-office use this spring. Aclaris CEO, Dr. Neal Walker addresses the launch, as wellA Specialty in Transition
https://practicaldermatology.com/topics/practice-management/a-specialty-in-transition/18343/Dermatology's past is impressive, but it's future is even more promising. In this final episode of our docu-series, hear how dermatologists are taking the lead in advocating for the specialty—and patients.Beyond SPF: Protecting the Skin
https://practicaldermatology.com/topics/skin-cancer-photoprotection/beyond-spf-protecting-the-skin-/18535/In addition to protecting the skin from sun damage, it's becoming increasingly important to consider pollution's role in skin aging. Arianne Shadi Kourosh, MD, and Rebecca Kazin, MD discuss the need for a well tailored regimen and what to look for in sun protection, barrier protection, cleaners, anGalderma's Differin Goes OTC, CoolSculpting Approved for Upper Arms, ZO Skin Acquires ReFissa
https://practicaldermatology.com/videos/dermwire-tv/galderma-s-differin-goes-otc-coolsculpting-approved-for-upper-arms-zo-skin-acquires-refissa/18549/Galderma's Differin Gel formulation of adapalene 0.1% is now available over the counter at major retail and drug stores in the US. ZELTIQ® Aesthetics' CoolSculpting is now FDA-cleared for fat reduction in the upper arms. ZO Skin Health has acquired the worldwide rights to ReFissa from Suneva MedicalTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goin